0000051143falseCHX00000511432025-07-232025-07-230000051143us-gaap:CommonStockMemberexch:XCHI2025-07-232025-07-230000051143us-gaap:CommonStockMemberexch:XNYS2025-07-232025-07-230000051143ibm:Notes2.875PercentDue2025Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes0.300PercentDue2026Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes1.250PercentDue2027Memberexch:XNYS2025-07-232025-07-230000051143ibm:A3375NotesDue2027Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes0.300PercentDue2028Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes1.750PercentDue2028Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes1.500PercentDue2029Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes0.875PercentDue2030Memberexch:XNYS2025-07-232025-07-230000051143ibm:A2.900NotesDue2030Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes1.750PercentDue2031Memberexch:XNYS2025-07-232025-07-230000051143ibm:A3625NotesDue2031Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes0.650PercentDue2032Memberexch:XNYS2025-07-232025-07-230000051143ibm:A3.150NotesDue2033Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes1.250PercentDue2034Memberexch:XNYS2025-07-232025-07-230000051143ibm:A3750NotesDue2035Memberexch:XNYS2025-07-232025-07-230000051143ibm:A3.450NotesDue2037Memberexch:XNYS2025-07-232025-07-230000051143ibm:A4875NotesDue2038Memberexch:XNYS2025-07-232025-07-230000051143ibm:Notes1.200PercentDue2040Memberexch:XNYS2025-07-232025-07-230000051143ibm:A4000NotesDue2043Memberexch:XNYS2025-07-232025-07-230000051143ibm:A3.800NotesDue2045Memberexch:XNYS2025-07-232025-07-230000051143ibm:Debentures7.00PercentDue2025Memberexch:XNYS2025-07-232025-07-230000051143ibm:Debentures6.22PercentDue2027Memberexch:XNYS2025-07-232025-07-230000051143ibm:Debentures6.50PercentDue2028Memberexch:XNYS2025-07-232025-07-230000051143ibm:Debentures5.875PercentDue2032Memberexch:XNYS2025-07-232025-07-230000051143ibm:Debentures7.00PercentDue2045Memberexch:XNYS2025-07-232025-07-230000051143ibm:Debentures7.125PercentDue2096Memberexch:XNYS2025-07-232025-07-23

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)

OF THE SECURITIES EXCHANGE ACT OF 1934

Date of Report: July 23, 2025

(Date of earliest event reported)

INTERNATIONAL BUSINESS MACHINES CORPORATION

(Exact name of registrant as specified in its charter)

New York

1-2360

13-0871985

(State of Incorporation)

(Commission File Number)

(IRS employer Identification No.)


One New Orchard Road Armonk, New York									10504
(Address of principal executive offices)									(Zip Code)

914-499-1900

(Registrant’s telephone number)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading symbol(s)

Name of each exchange on which registered

Capital stock, par value $.20 per share

IBM

New York Stock Exchange

NYSE Texas

2.875% Notes due 2025

IBM 25A

New York Stock Exchange

0.300% Notes due 2026

IBM 26B

New York Stock Exchange

1.250% Notes due 2027

IBM 27B

New York Stock Exchange

3.375% Notes due 2027

IBM 27F

New York Stock Exchange

0.300% Notes due 2028

IBM 28B

New York Stock Exchange

1.750% Notes due 2028

IBM 28A

New York Stock Exchange

1.500% Notes due 2029

IBM 29

New York Stock Exchange

0.875% Notes due 2030

IBM 30A

New York Stock Exchange

2.900% Notes due 2030

IBM 30C

New York Stock Exchange

1.750% Notes due 2031

IBM 31

New York Stock Exchange

3.625% Notes due 2031

IBM 31B

New York Stock Exchange

0.650% Notes due 2032

IBM 32A

New York Stock Exchange

3.150% Notes due 2033

IBM 33A

New York Stock Exchange

1.250% Notes due 2034

IBM 34

New York Stock Exchange

3.750% Notes due 2035

IBM 35

New York Stock Exchange

3.450% Notes due 2037

IBM 37

New York Stock Exchange

4.875% Notes due 2038

IBM 38

New York Stock Exchange

1.200% Notes due 2040

IBM 40

New York Stock Exchange

4.000% Notes due 2043

IBM 43

New York Stock Exchange

3.800% Notes due 2045

IBM 45A

New York Stock Exchange

7.00% Debentures due 2025

IBM 25

New York Stock Exchange

6.22% Debentures due 2027

IBM 27

New York Stock Exchange

6.50% Debentures due 2028

IBM 28

New York Stock Exchange

5.875% Debentures due 2032

IBM 32D

New York Stock Exchange

7.00% Debentures due 2045

IBM 45

New York Stock Exchange

7.125% Debentures due 2096

IBM 96

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial Condition.

The registrant’s press release dated July 23, 2025, regarding its financial results for the period ended June 30, 2025, including consolidated financial statements for the period ended June 30, 2025, is Exhibit 99.1 of this Form 8-K.

In an effort to provide investors with additional information regarding the company’s results as determined by generally accepted accounting principles (GAAP), the company has disclosed in the attached press release certain non-GAAP information which management believes provides useful information to investors. Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are included in the press release, which is Exhibit 99.1 to this Form 8-K. The rationale for management’s use of non-GAAP measures is included in Exhibit 99.2 to this Form 8-K.

The information in this Item 2.02, including the corresponding Exhibits 99.1 and 99.2, is being furnished with the Commission and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934.

Item 9.01. Financial Statements and Exhibits.

(d)Exhibits

The following exhibits are being furnished as part of this report:


Exhibit No.						Description of Exhibit
99.1						Earnings Release of the Registrant, dated July 23, 2025
99.2						Non-GAAP Metrics and Other Financial Information

The following exhibit is being filed as part of this report:


Exhibit No.						Description of Exhibit
104						Cover Page Interactive Data File (embedded within the Inline XBRL Document)

IBM’s web site (www.ibm.com) contains a significant amount of information about IBM, including financial and other information for investors (www.ibm.com/investor/). IBM encourages investors to visit its various web sites from time to time, as information is updated and new information is posted.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.


Date: July 23, 2025

	By:	/s/ Nicolás A. Fehring
		Nicolás A. Fehring
		Vice President and Controller

INTERNATIONAL BUSINESS MACHINES CORP 8-K